Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.
Arch. Intern. Med., 165(15):1782-7 (2005)
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human
Clin. Cancer Res., Aug;11(16):5920-7 (2005)
Incidence of venous thromboembolism and its effect on survival among patients with common cancers.
Arch. Intern. Med., Feb;166(4):458-64 (2006)
Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
J. Clin. Oncol., Mar;24(7):1112-8 (2006)
25th Chemotherapy Foundation Symposium. Innovative Cancer Therapy for Tomorrow. 6-10 November 2007, New York, NY, USA.
IDrugs., Feb;11(2):90-3 (2008)
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.
Clin. Breast Cancer., Dec;8(6):511-5 (2008)
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
J. Clin. Oncol., May;27(13):2163-9 (2009)
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors.
Ann. Oncol., Apr;23(4):1023-9 (2012)
Genetic evaluation of cancer: the importance of family history.
Tex Med., Feb;97(2):40-5 (2001)
Adjuvant therapy for breast cancer: who should get what?
West. J. Med., Apr;174(4):284-7 (2001)
Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment.
Oncol. Rep., May;15(5):1299-304 (2006)
Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
J. Clin. Oncol., Jan;25(1):70-6 (2007)
The incidence of venous thromboembolism among patients with primary lung cancer.
J. Thromb. Haemost., Apr;6(4):601-8 (2008)
Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data.
Bioinformatics., Jan;25(2):251-7 (2009)
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.
Blood., Apr;113(17):3911-7 (2009)
High-mannose glycans are elevated during breast cancer progression.
Mol. Cell Proteomics., Jan;10(1):M110.002717 (2011)
Richter's Syndrome With Aberrant CD2 and CD4 Expression.
Co-Author, "Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer."
Journal of Clinical Oncology
Co-Author, "A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338."
Clinical Breast Cancer
Co-Author, "The incidence of venous thromboembolism among patients with primary lung cancer."
Journal of Thrombosis and Haemostasis